Clinical Trials in Detroit

Showing 10421-10440 of 19,719 trials

Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

NCT01812668

This pilot clinical trial studies cabozantinib-s-malate in treating patients with hormone-resistant metastatic prostate cancer. Cabozantinib-s-malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth

Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more

Barbara Ann Karmanos Cancer Institute20 participantsStarted Mar 2013

Detroit, Michigan, United States

COMPLETEDPhase 2/3< 1 mile

Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer

NCT03093870

This protocol for Varlitinib is developed for the treatment of Biliary Tract Cancer. Varlitinib (also known as ASLAN001) is a small-molecule, adenosine triphosphate competitive inhibitor of the tyrosine kinases - epidermal growth factor receptor (EGFR), human epidermal growth factor receptor (HER)2, and HER4. Varlitinib may be beneficial to subjects with cancer by simultaneous inhibition of these receptors. The purpose of this study is to determine the safety and efficacy of Varlitinib in combination with capecitabine for the treatment of Biliary Tract Cancer. Treatment groups are Varlitinib+capecitabine and Placebo + capecitabine

Biliary Tract Cancer

ASLAN Pharmaceuticals151 participantsStarted Jul 2017

Gilbert, Arizona, United States • Detroit, Michigan, United States • St Louis, Missouri, United States +18 more locations

Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer

Find Trials by Condition in Detroit

IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents

A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome

A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies

Project IntERact Study

Natural History of Rett Syndrome & Related Disorders

Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)

Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis

A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer

A Study To Compare Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Post-Herpetic Neuralgia

Rare Diseases Clinical Research Network: Neurophysiological Correlates

Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria

Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART)

Biobanking of Rett Syndrome and Related Disorders

Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission

Registry of Subject Treated With ClariFix

StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects

Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.